Article Details

Cour Pharmaceuticals' PBC Treatment Gets FDA Orphan Drug Designation - PharmTech

Retrieved on: 2025-01-09 19:27:30

Tags for this article:

Click the tags to see associated articles and topics

Cour Pharmaceuticals' PBC Treatment Gets FDA Orphan Drug Designation - PharmTech. View article details on hiswai:

Excerpt

8, 2025 company press release (1). Orphan drug status is given to treatments for rare diseases, which within the parameters of FDA are characterized ...

Article found on: www.pharmtech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up